Ultrasound-enhanced exosome secretion and antibody-free SERS profiling for Alzheimer's disease via iPSC-derived cortical organoids.

Authors

Jinhee Yoo, Youngjun Kim, Won Jong Yu, Seongmin Kim, Yongjae Jo, Hanjun Cho, Hyunsu Park, Luke P Lee, Jong-Chan Park, Inki Kim, Byullee Park

Published in

Science advances. Volume 12. Issue 39. Pages eaed3930. Sep 25, 2026. Epub Sep 23, 2026.

Abstract

Exosomes offer a promising vehicle for noninvasive diagnosis of neurodegenerative diseases by carrying multiple biomarkers across the blood-brain barrier. However, traditional exosome analysis often misses subtle genotype-specific variations because of weak signals from a few exosomes, reliance on markers, and limited understanding of disease signatures. Here, we present a sound way to understand Alzheimer's disease through label-free surface-enhanced Raman scattering (SERS) profiling of cortical organoid-derived exosomes. Initially, we enhanced exosomal SERS signal levels by optimizing ultrasound parameters to increase exosome secretion from cortical organoids. Using this strategy, we distinguished apolipoprotein E genotype-dependent differences in intact exosomal fingerprints. Transcriptome analysis confirmed that ultrasound stimulation increased exosome secretion and up-regulated exosome-related genes functionally linked to Alzheimer's pathology. Ultrasound-based stimulation and label-free exosome profiling reveal genotype-specific pathologies, providing a precision-diagnostic framework for Alzheimer's disease.

PMID:
42777042
Bibliographic data and abstract were imported from PubMed on 24 Sep 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.